RYTM
Rhythm Pharmaceuticals Inc
NASDAQ: RYTM · HEALTHCARE · BIOTECHNOLOGY
$82.12
-2.45% today
Updated 2026-04-29
Market cap
$5.61B
P/E ratio
—
P/S ratio
29.55x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$55 – $122
Volume
0.9M
Rhythm Pharmaceuticals Inc (RYTM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $35000.00 | $3.15M | $23.64M | $77.43M | $130.13M | $189.76M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | +8911.4% | +649.5% | +227.6% | +68.1% | +45.8% |
| Cost of revenue | — | — | $0.00 | $0.00 | $144000.00 | $223000.00 | $442000.00 | $834000.00 | $690000.00 | $599000.00 | $2.13M | $9.30M | $13.37M | $19.49M |
| Gross profit | — | — | $0.00 | $0.00 | $-144000.00 | $-223000.00 | $-442000.00 | $-834000.00 | $-690000.00 | $2.56M | $21.50M | $68.13M | $116.76M | $170.26M |
| Gross margin | — | — | — | — | — | — | — | — | -1971.4% | 81.0% | 91.0% | 88.0% | 89.7% | 89.7% |
| R&D | $15.68M | $18.02M | $5.28M | $7.15M | $19.59M | $22.89M | $50.34M | $109.45M | $90.45M | $104.13M | $108.63M | $134.95M | $237.96M | $167.34M |
| SG&A | $2.46M | $3.43M | $1.21M | $3.42M | $6.31M | $9.52M | $28.08M | $36.55M | $46.13M | $68.49M | $92.03M | $111.47M | $144.30M | $194.94M |
| Operating income | $-18.14M | $-21.45M | $-6.49M | $-10.57M | $-25.91M | $-32.41M | $-78.42M | $-146.00M | $-136.57M | $-170.06M | $-179.16M | $-184.36M | $-265.50M | $-192.02M |
| Operating margin | — | — | — | — | — | — | — | — | -390214.3% | -5391.9% | -757.9% | -238.1% | -204.0% | -101.2% |
| EBITDA | $-18.12M | $-21.41M | — | $-10.07M | $-25.76M | $-32.19M | $-77.97M | $-145.17M | $-135.88M | $-168.90M | $-174.25M | $-168.46M | $-238.09M | $-174.12M |
| EBITDA margin | — | — | — | — | — | — | — | — | -388242.9% | -5355.1% | -737.1% | -217.6% | -183.0% | -91.8% |
| EBIT | $-18.14M | $-21.43M | $-6.49M | $-10.57M | $-25.91M | $-32.41M | $-78.42M | $-146.00M | $-136.57M | $-170.06M | $-175.92M | $-170.22M | $-239.65M | $-175.46M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.45M | $5.20M | $13.89M | $20.60M | $20.58M |
| Income tax | — | — | $0.00 | $0.00 | $0.00 | $1.07M | $4.35M | $-6.11M | $-3.27M | $-1.60M | $1.96M | $564000.00 | $346000.00 | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3.3% | -6.2% | 4.3% | 2.4% | 2.3% | -1.1% | -0.3% | -0.1% | 0.0% |
| Net income | $-18.13M | $-21.43M | $-6.49M | $-11.07M | $-25.87M | $-33.71M | $-74.06M | $-134.62M | $-130.73M | $-68.01M | $-181.12M | $-184.68M | $-260.60M | $-196.54M |
| Net income growth (YoY) | — | -18.2% | +69.7% | -70.5% | -133.6% | -30.3% | -119.7% | -81.8% | +2.9% | +48.0% | -166.3% | -2.0% | -41.1% | +24.6% |
| Profit margin | — | — | — | — | — | — | — | — | -373505.7% | -2156.2% | -766.2% | -238.5% | -200.3% | -103.6% |